Access to new Alzheimer's medicines for older adults
Cost and Non-Cost Barriers to Use of Novel AD Therapeutics among Older Adults
This project explores which costs and other obstacles stop older adults, especially Latino patients, from getting new Alzheimer's medicines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11182690 on NIH RePORTER |
What this research studies
You might be invited to a short interview if you are a Latino older adult at high risk for Alzheimer's, a patient with dementia, or a caregiver, so researchers can hear your experiences with paying for and using new treatments. Your answers will help shape a larger, national online survey of older adults run through the Understanding America Study. The team will also analyze Medicare and encounter records to see real-world use patterns, and use computer simulation models to estimate how wider use could affect health, costs, and quality of life. Together these steps aim to link personal experiences with large-scale data to show where barriers occur and who is most affected.
Who could benefit from this research
Good fit: Ideal candidates include US-based older adults with or at high risk for Alzheimer's disease or related dementias, especially Latino patients, and their caregivers.
Not a fit: People younger than older-adult age groups, those without dementia or dementia risk, or individuals living outside the United States are unlikely to be included.
Why it matters
Potential benefit: If successful, the work could point to specific cost or non-cost barriers to access so policymakers, providers, or programs can help more people get new Alzheimer's treatments.
How similar studies have performed: Previous research has shown that cost and access reduce uptake of expensive dementia drugs, but combining interviews, a national survey, claims analysis, and simulation is a more comprehensive approach than most prior studies.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Jacobson, Mireille — University of Southern California
- Study coordinator: Jacobson, Mireille
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.